Cargando…

Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram

[Image: see text] Three photoaffinity ligands (PALs) for the human serotonin transporter (hSERT) were synthesized based on the selective serotonin reuptake inhibitor (SSRI), (S)-citalopram (1). The classic 4-azido-3-iodo-phenyl group was appended to either the C-1 or C-5 position of the parent molec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Vivek, Yarravarapu, Nageswari, Lapinsky, David J., Perley, Danielle, Felts, Bruce, Tomlinson, Michael J., Vaughan, Roxanne A., Henry, L. Keith, Lever, John R., Newman, Amy Hauck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515784/
https://www.ncbi.nlm.nih.gov/pubmed/26153715
http://dx.doi.org/10.1021/acs.jmedchem.5b00682
_version_ 1782382970910277632
author Kumar, Vivek
Yarravarapu, Nageswari
Lapinsky, David J.
Perley, Danielle
Felts, Bruce
Tomlinson, Michael J.
Vaughan, Roxanne A.
Henry, L. Keith
Lever, John R.
Newman, Amy Hauck
author_facet Kumar, Vivek
Yarravarapu, Nageswari
Lapinsky, David J.
Perley, Danielle
Felts, Bruce
Tomlinson, Michael J.
Vaughan, Roxanne A.
Henry, L. Keith
Lever, John R.
Newman, Amy Hauck
author_sort Kumar, Vivek
collection PubMed
description [Image: see text] Three photoaffinity ligands (PALs) for the human serotonin transporter (hSERT) were synthesized based on the selective serotonin reuptake inhibitor (SSRI), (S)-citalopram (1). The classic 4-azido-3-iodo-phenyl group was appended to either the C-1 or C-5 position of the parent molecule, with variable-length linkers, to generate ligands 15, 22, and 26. These ligands retained high to moderate affinity binding (K(i) = 24–227 nM) for hSERT, as assessed by [(3)H]5-HT transport inhibition. When tested against Ser438Thr hSERT, all three PALs showed dramatic rightward shifts in inhibitory potency, with K(i) values ranging from 3.8 to 9.9 μM, consistent with the role of Ser438 as a key residue for high-affinity binding of many SSRIs, including (S)-citalopram. Photoactivation studies demonstrated irreversible adduction to hSERT by all ligands, but the reduced (S)-citalopram inhibition of labeling by [(125)I]15 compared to that by [(125)I]22 and [(125)I]26 suggests differences in binding mode(s). These radioligands will be useful for characterizing the drug–protein binding interactions for (S)-citalopram at hSERT.
format Online
Article
Text
id pubmed-4515784
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-45157842015-08-01 Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram Kumar, Vivek Yarravarapu, Nageswari Lapinsky, David J. Perley, Danielle Felts, Bruce Tomlinson, Michael J. Vaughan, Roxanne A. Henry, L. Keith Lever, John R. Newman, Amy Hauck J Med Chem [Image: see text] Three photoaffinity ligands (PALs) for the human serotonin transporter (hSERT) were synthesized based on the selective serotonin reuptake inhibitor (SSRI), (S)-citalopram (1). The classic 4-azido-3-iodo-phenyl group was appended to either the C-1 or C-5 position of the parent molecule, with variable-length linkers, to generate ligands 15, 22, and 26. These ligands retained high to moderate affinity binding (K(i) = 24–227 nM) for hSERT, as assessed by [(3)H]5-HT transport inhibition. When tested against Ser438Thr hSERT, all three PALs showed dramatic rightward shifts in inhibitory potency, with K(i) values ranging from 3.8 to 9.9 μM, consistent with the role of Ser438 as a key residue for high-affinity binding of many SSRIs, including (S)-citalopram. Photoactivation studies demonstrated irreversible adduction to hSERT by all ligands, but the reduced (S)-citalopram inhibition of labeling by [(125)I]15 compared to that by [(125)I]22 and [(125)I]26 suggests differences in binding mode(s). These radioligands will be useful for characterizing the drug–protein binding interactions for (S)-citalopram at hSERT. American Chemical Society 2015-07-08 2015-07-23 /pmc/articles/PMC4515784/ /pubmed/26153715 http://dx.doi.org/10.1021/acs.jmedchem.5b00682 Text en Copyright © 2015 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Kumar, Vivek
Yarravarapu, Nageswari
Lapinsky, David J.
Perley, Danielle
Felts, Bruce
Tomlinson, Michael J.
Vaughan, Roxanne A.
Henry, L. Keith
Lever, John R.
Newman, Amy Hauck
Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram
title Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram
title_full Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram
title_fullStr Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram
title_full_unstemmed Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram
title_short Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram
title_sort novel azido-iodo photoaffinity ligands for the human serotonin transporter based on the selective serotonin reuptake inhibitor (s)-citalopram
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515784/
https://www.ncbi.nlm.nih.gov/pubmed/26153715
http://dx.doi.org/10.1021/acs.jmedchem.5b00682
work_keys_str_mv AT kumarvivek novelazidoiodophotoaffinityligandsforthehumanserotonintransporterbasedontheselectiveserotoninreuptakeinhibitorscitalopram
AT yarravarapunageswari novelazidoiodophotoaffinityligandsforthehumanserotonintransporterbasedontheselectiveserotoninreuptakeinhibitorscitalopram
AT lapinskydavidj novelazidoiodophotoaffinityligandsforthehumanserotonintransporterbasedontheselectiveserotoninreuptakeinhibitorscitalopram
AT perleydanielle novelazidoiodophotoaffinityligandsforthehumanserotonintransporterbasedontheselectiveserotoninreuptakeinhibitorscitalopram
AT feltsbruce novelazidoiodophotoaffinityligandsforthehumanserotonintransporterbasedontheselectiveserotoninreuptakeinhibitorscitalopram
AT tomlinsonmichaelj novelazidoiodophotoaffinityligandsforthehumanserotonintransporterbasedontheselectiveserotoninreuptakeinhibitorscitalopram
AT vaughanroxannea novelazidoiodophotoaffinityligandsforthehumanserotonintransporterbasedontheselectiveserotoninreuptakeinhibitorscitalopram
AT henrylkeith novelazidoiodophotoaffinityligandsforthehumanserotonintransporterbasedontheselectiveserotoninreuptakeinhibitorscitalopram
AT leverjohnr novelazidoiodophotoaffinityligandsforthehumanserotonintransporterbasedontheselectiveserotoninreuptakeinhibitorscitalopram
AT newmanamyhauck novelazidoiodophotoaffinityligandsforthehumanserotonintransporterbasedontheselectiveserotoninreuptakeinhibitorscitalopram